Fabrazyme 35 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDL09
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,829
Award facts
- Contract value 100% obligated
- $33,828.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,828.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fabrazyme 35 mg vials. The contract, which became effective on August 12, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its core business of distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. The company's portfolio of federal contract awards demonstrates consistent success in securing delivery orders for specialized pharmaceutical products, including oncology treatments, vaccines, and injectable medications. This particular delivery order for Fabrazyme, an enzyme replacement therapy medication, aligns with the company's established role as a direct pharmaceutical distributor supporting DoD medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FDL09?
SPE2DB25FDL09 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FDL09 worth?
The government has obligated $33,829 on SPE2DB25FDL09.
Is contract SPE2DB25FDL09 an order under another contract?
Yes. SPE2DB25FDL09 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL09 competed?
The extent of competition for SPE2DB25FDL09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award